Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS for Postoperative Brain Tumor Patients

NCT: NCT07530536 · RECRUITING

NCT IDNCT07530536
StatusRECRUITING
Start Date2026-06
Completion2028-04

Brief Summary

When doctors perform surgery to remove brain tumors, the goal is to take out as much of the tumor as possible while keeping the patient's brain functions intact. However, sometimes patients have trouble with movements like walking or using their hands after surgery. One reason for this is unintentional damage to important areas of the brain during the operation. A technique called Transcranial Magnetic Stimulation (TMS) might help patients recover these lost abilities faster. The investigators are conducting a study to see if TMS can help patients recover their movement abilities after brain tumor surgery. TMS uses magnetic pulses to stimulate specific parts of the brain. In this study, the investigators will treat six patients with TMS once per day for three days in a row. Three patients with recent movement difficulties one to two weeks after surgery will be recruited for this study; they will also receive physical therapy. An additional three patients with persisting movement difficulties up to three years after tumor surgery will also be recruited for this study, regardless of whether or not they receive physical therapy. The investigators will use two standard tests to see how well patients can move before and after the TMS treatment. These tests will help the investigators understand if TMS is making a difference in their recovery.

Frequently Asked Questions

What is rTMS for Postoperative Brain Tumor Patients?

rTMS for Postoperative Brain Tumor Patients is a clinical trial registered under NCT07530536. Current status: RECRUITING.

What is the status of NCT07530536?

The current status of NCT07530536 (rTMS for Postoperative Brain Tumor Patients) is: RECRUITING.

When did rTMS for Postoperative Brain Tumor Patients start?

rTMS for Postoperative Brain Tumor Patients started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.